Powerful Medical secures €7.5M in funding from European Innovation Council

Powerful Medical has secured €7.5 million funding from European Innovation Council (EIC).

“We are immensely grateful for the EIC’s recognition and support, which propels us closer to achieving our mission of saving lives on a global scale,” said Martin Herman, CEO of Powerful Medical. “This investment fuels our ambition to broaden our reach within the EU and pioneer entry into the US, a journey supported by early believers like Life Extension Ventures, Venture to Future Fund (backed by European Investment Bank), Zero Gravity Capital, and our partners at Civitta.”

The integration of PMcardio into existing hospital workflows streamlines the triage process with an AI-augmented patient assessment pathway and enables prompt interventions for those with the most acute conditions, leading to improved outcomes and increased efficiency for institutions.

“The impact of our technology is not limited to the immediate treatment of heart attacks; it extends into the future well-being of patients. Our AI models in development focus on ECG-based screening for heart failure as early as asymptomatic patients presenting for a routine check-up to their GP and early recognition of sudden cardiac death predictors (such as Brugada and Hypertrophic Cardiomyopathy), ensuring patients have the best chance for a healthier, longer life,” states Dr. Robert Herman, Chief Medical Officer at Powerful Medical.

Backed by the European Innovation Council, Powerful Medical is escalating its clinical validation efforts and expanding its footprint throughout Europe. Awaiting FDA approval and with ongoing pilots in the US, the company is strategically positioning itself for an expansive global reach. 
MB Bureau